5 things to consider when choosing your drug product CDMO Monday, 29 January 2024
How to choose the right CDMO partner for drug product? Discover our TOP 5 things to consider!
How to choose the right CDMO partner for drug product? Discover our TOP 5 things to consider!
Watch Episode 2 of our Customer Journey series on CARBOGEN AMCIS Drug Products, ADC & Bioconjugation services!
In addition to Drug Substance services, CARBOGEN AMCIS is currently in an on-going growth phase of its Drug Product services capabilities. Discover our new article on Formulation and Development of Injectable Drug Product at CARBOGEN AMCIS.
Brochure
Learn more about Development and Aseptic Production of Drug Products at CARBOGEN AMCIS
Our new state-of-the-art facility will allow for larger capacities to supply our customers with clinical batches for phase III clinical trials and small-scale for commercial.
Our new dedicated site for the production of liquid and lyophilised sterile drug products, in Saint-Beauzire (France) was inaugurated on February 3rd. Watch the full video of our new Drug Products Facility Opening Ceremony.
The inauguration of our new production site dedicated to the manufacture of drug products took place on Friday 3 February. The company gathered 250 guests to celebrate this milestone for the company.
Liquid and lyophilised forms production line
CARBOGEN AMCIS expands capacity for parenteral drug manufacturing.
An insight by Caroline Ailhas, Ph.D. - Project and Pharmaceutical Development Director at CARBOGEN AMCIS
Pharmaceutical development of drug products is a complex and challenging process. It is composed but not limited to formulation development, process development and transfer to upper scale.